A kind of amplification-free nucleic acid detection method and its application
By combining CRISPR technology and digital microfluidic control technology on the microarray chip, nucleic acid detection is directly carried out in the micropore, solving the problems of cumbersome detection process and insufficient sensitivity in the existing technology, and achieving high sensitivity to the new coronavirus. Fast and accurate detection.
Patent Information
- Application Number
- CN202210180046.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-02-25
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2042-02-25
AI Technical Summary
The existing nucleic acid detection methods have problems with cumbersome testing procedures, long time and aerosol contamination caused by nucleic acid amplification in the early diagnosis of novel coronavirus pneumonia, and the sensitivity of the amplification-free technology is not enough to meet clinical needs.
Micron-level microarray chips are used to realize digital CRISPR detection, and the capture probe reacts with the CRISPR reaction system in the micropores of the microfluidic chip to avoid nucleic acid amplification, improve detection sensitivity and reduce background noise.
The detection of nucleic acid molecules as low as 1aM is achieved, which is simple and fast, meets the needs of early clinical diagnosis, and reduces the risk of diffusion dilution and contamination, improving the specificity and accuracy of the detection.
